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Netherlands; eDepartment of Biomedical Signals and Systems, Telemedicine cluster, University of Twente, Enschede, the Netherlands
ABSTRACT
Introduction: For patients with peripheral arterial disease (PAD), the various components of telemedi-
cine, such as telemonitoring, telecoaching, and teleconsultation, could be valuable in daily manage-
ment. The objective of this review was to give an overview of the current use of telemedicine
interventions in PAD.
Areas covered: A literature search was performed for studies that evaluated patients with PAD of the
aorto-pedal trajectory, who were monitored by telemedicine and acted upon accordingly. The primary
outcome was health-related outcomes. The studies that were found focused mainly on wearable
activity monitoring and telecoaching in PAD (n = 4) or wound monitoring after vascular surgery
(n = 2). Main results indicate that telemedicine interventions are able to detect (post-operative)
complications early, improve functional capacity and claudication onset time, and improve PAD
patients’ quality of life.
Expert opinion: The use of telemedicine in PAD patients is still an under-explored area. Studies
investigating the use of telemedicine in PAD are very limited and show varying results. Owing to its
high potential in improving physical ability, lifestyle coaching, and timely detection of deterioration,
future research should focus on proper implementation of telemedicine in PAD patients, including
clinical and feasibility outcomes, effect on workload of nurses, and cost-efficiency.
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Telemedicine is the use of telecommunications technology to
provide health care from a distance. Its implementation in
medical care has become increasingly popular in recent
years, especially in patients with chronic diseases [1–4]. In
chronic heart disease, telemedicine is associated with
a reduction of hospitalization and readmissions, lower mortal-
ity, and improved clinical outcome and cost-effectiveness of
care [5]. The use of telemedicine in health care meets the
tendency toward personalized medicine and the need to con-
trol rising health-care costs, including an individual approach
and migration of care toward home with the use of remote
monitoring, education of patients, and virtual visits to medical
professionals [2].
Telemedicine can be divided into educational or supportive
websites, telecoaching, telemonitoring, telerehabilitation, and
teleconsultation [6]. Various aspects, such as telemonitoring,
telecoaching, and teleconsultation, can be potentially impor-
tant tools in the treatment of patients with peripheral arterial
disease (PAD). Patients with PAD are usually old, frail and
multimorbid, and could benefit from monitoring of health
parameters and vascular risk factors. Moreover, these patients
frequently have mobility issues and could thus particularly
benefit from techniques that reduce the need for hospital
visits. Possible targets for monitoring include regulation of
hypertension, weight, renal function, diabetes management,
hyperlipidemia control, smoking behavior, and wound status.
In addition, telemedicine could be used to improve secondary
prevention and lifestyle coaching.
In this systematic review, we summarize the currently avail-
able literature on the application of telemedicine in patients
with PAD.
2. Methods
This report was written in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [7]. The review protocol was prospectively
registered in the PROSPERO database (ID: CRD42019132621).
2.1. Literature search
PubMed, CINAHL (via EBSCO), and Embase databases were
searched for eligible articles published between 1 January 2009,
and 1 March 2019. Search terms describing telemedicine were
combined with terms for arterial diseases, including controlled
CONTACT Jean-Paul P.M. De Vries j.p.p.m.de.vries@umcg.nl Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen,
Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
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terms (Medical Subject Headings in PubMed, Subject Headings in
CINAHL and Emtree in Embase) and also free-text terms. The full
search strategy is added as Supplementary. Additional studies
were identified by reviewing the reference lists of the studies
found in the search.
2.2. Selection criteria
Articles were eligible according to the PICO framework if they
included patients with PAD of the aorta-pedal trajectory (P),
a telemedicine intervention based on patient monitoring (I),
either a control group receiving standard of care or no control
group (C), and patient outcome measures as described in
section 2.4 (O). Telemonitoring was defined as in-hospital or
transmural monitoring of patients through wireless measure-
ment of vital parameters or activity or through electronic
questionnaires regarding health, based on which coaching or
feedback might be provided. Telemonitoring intervention is
defined if telemonitoring is used to intervene if necessary.
Exclusion criteria were: no PAD patients; no telemonitoring
intervention; no outcome measures as described in section
2.4; patients younger than 18 years old; or no full-text avail-
able. Access to full-text articles was gained through our med-
ical library or in case of unavailability through direct contact
with the author. If no full text was available after these
attempts, articles were excluded. There were no restrictions
on the setting of telemedicine (in-hospital, long-term, peri-
operative, and at home), language or sample size. Because
the subject of telemedicine is yet a new and growing field of
expertise, we decided not to limit the search to specific study
types, with the exception of case reports, reviews, commen-
taries, letters to the editor, or conference abstracts.
2.3. Data collection and quality assessment
After duplicates were removed, two authors (MH, SK) indepen-
dently screened the titles and abstracts of the identified stu-
dies for relevance. The full text of the remaining relevant
studies were read by two authors (MH, SK), and a final selec-
tion of relevant studies was made. In case of discrepancies
between the two reviewers, a third author was consulted (KM).
The methodological quality of the randomized and non-
randomized studies was assessed using the checklist
described by Downs and Black [8]. Two reviewers (MH, RB)
independently evaluated the study quality, and discrepancies
were discussed until consensus was reached. The thresholds
used to classify study quality were good (9–16), moderate (17–
23), and poor (below 14) [6].
2.4. Outcome measures and data analysis
The primary outcome measures were disease-specific health-
related outcomes (wound) complications, and quality of life
(QoL). Secondary outcomes were office visits, hospital read-
missions, and hospital length of stay. Data extracted included
the year of publication, study design, study period, study
inclusion criteria, age of included patients, sample size, control
group, interventions, telemedicine instruments, and outcome
measures, as mentioned. Reported baseline and post-
interventional change in outcome measures were extracted
to compare the intervention group with the control group.
The heterogeneity in study design, type of telemedicine
applied, and outcome measures described precluded pooling
of data or performing a meta-analysis. Therefore, we present
a narrative summary of the included studies consisting of
study characteristics and outcomes. Subgroups of different
intervention types are presented separately.
3. Results
3.1. Description of study selection
A systematic literature search identified 1249 records (Figure 1).
After the duplicates were removed, 872 records remained for
the title and abstract screening. From these, 854 were excluded
because they did not meet the inclusion criteria, mainly because
other patient populations were described (mostly carotid or
cerebral artery diseases) or a telemonitoring intervention was
absent. Full-text assessment of the remaining 18 articles resulted
in six articles fulfilling the inclusion criteria of this review [17,24–
28]. The characteristics of the included studies are summarized
in Table 1. Table 2 reports the outcomes of the included studies.
The excluded full-text papers with the reason for exclusion are
listed in Table 3.
The included studies described a total of 477 patients, with
a mean sample size of 80 patients (range, 19–200), and were
all published in 2018 or 2019. The ages of these patients
ranged from 62.5 to 70.2 years. Five randomized controlled
trials (RCTs) were included [17,24,25,27,28] and one prospec-
tive cohort study [26]. Two studies were focused on telemo-
nitoring tools to monitor surgical site infections (SSIs) [17,26]
and post-discharge complications [17] after vascular surgery.
The four other RCTs included telecoaching tools in patients
with PAD who underwent home-based exercise intervention
[24,27,28] or a self-management program [25].
3.2. Methodological quality of included studies
The study quality scores are reported in Table 1. The table
with the scoring for the different categories of the Downs and
Black checklist is displayed in Supplementary Table I. No stu-
dies were judged as having a poor study quality. Three were of
moderate quality and three of high study quality. Most studies
Article highlights
● Currently reported telemedicine interventions in patients with per-
ipheral arterial disease focus on wearable activity monitoring, tele-
coaching, teleconsultation, and wound monitoring.
● Only six recent studies describe health outcomes after telemedicine
interventions in patients with peripheral arterial disease; however,
evidence for additional clinical value is based on limited numbers of
patients, and no robust conclusions can be drawn from the literature.
● Increasing technological possibilities for telemedicine offer great
potential in (self-)care of patients with peripheral arterial disease,
justifying further research on the implementation of telemedicine in
these patients.
2 M. E. HAVEMAN ET AL.
scored low at blinding subjects and clinicians to the interven-
tion and outcome measurement and at making clear which
analysis was not planned at the outset of the study.
3.3. Post-operative telemonitoring
One feasibility study and one RCT on post-operative telemo-
nitoring were identified.
Gunter et al. [26] evaluated the feasibility and use of
a WoundCheck app in a prospective analysis of 47 consecutive
patients, of which 40 completed a 14-day post-operative fol-
low-up protocol. All patients underwent a vascular surgical
procedure with an incision of at least 3 cm and were trained
to use the WoundCheck app during admission. Patients used
the app to send a daily photo of the wound and to answer
questions about their recovery. During follow-up, eight SSIs
were recorded, seven of which were detected using the
WoundCheck app, with no false positives. Three patients
were readmitted: one after falling on the amputation stump,
one for respiratory failure, and one because of an unresolved
SSI after antibiotic therapy. The authors concluded that the
protocol including the WoundCheck app can be completed by
patients and health-care providers. In addition, the app led to
the detection and treatment of SSIs before routine follow-up
visits occurred in standard care.
Moussa et al. [17] evaluated clinical outcomes, use, feasi-
bility, patient satisfaction, and QoL after vascular procedures
with infrainguinal incisions in patients receiving TeleHealth
Electronic Monitoring (THEM) or standard care. THEM com-
prises daily measurements of blood pressure, heart rate, oxy-
gen saturation, weight, and temperature, which are manually
registered by the user in a tablet and monitored by a health-
care provider for abnormalities. Of 30 patients, 16 were ran-
domly assigned to the intervention group and instructed to
record the THEM parameters until the first follow-up visit. The
tablet was also used for daily and weekly quiz questions and
system alerts based on measurements or quiz answers. Care
managers monitored values daily, contacted patients based on
the system alerts, and requested pictures of the surgical site
for assessment and comparison. No significant differences
Figure 1. PRISMA flow diagram of study selection.
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































EXPERT REVIEW OF MEDICAL DEVICES 5
were found between the groups in the number of readmis-
sions within 30 days, office visits, or SSI, as reported in Table 2.
However, care managers identified more wound problems in
the THEM group, but without significance (5 vs. 1, p = 0.175).
Patients in the THEM group had a significantly more pro-
nounced increase between the pre- and post-operative QoL
subscales of physical function (7.5 vs. 1.1, p = 0.002) and
physical role (8.7 vs. 1.1, p = 0.001) as measured with the
8-Item Short Form Health Survey. The authors concluded
that THEM was technically feasible, improved patient satisfac-
tion, and successfully merged remotely generated information
with patient management.
3.4. Telecoaching in PAD
Four RCTs were identified that investigated the use of tele-
medicine in patients with PAD.
Davins Riu et al. [25] created a telehealth program called
Control Telehealth Claudication Intermittent (CONTECI) to
improve patient education, empowerment, and self-
management. In this RCT, they assessed the efficacy of
CONTECI as a monitoring tool in PAD patients with intermittent
claudication over 12 months in clinical aspects (walking dis-
tance, Fontaine classification, number of surgical interventions),
patient satisfaction, and QoL. Of the 150 included patients, 75
were randomly assigned to the intervention group and 75 to
the control group. The intervention group used the CONTECI
program from a computer or mobile device every 3 months to
answer a dynamic questionnaire based on which they were
advised to continue as before or to request a visit. The control
group was monitored during standard visits every 6 months.
QoL improved in both groups and improved significantly in the
intervention group between baseline and 12 months’ follow-up
(67.9 vs. 72.3, p = 0.047). However, no significant differences in
QoL at 12 months were found between the two groups (p =
0.195). Control visits were reduced by 95.95% in the interven-
tion group, and therefore, the frequency of control visits was
significantly lower than in the control group (2.2 ± 0.6 vs. 0.3 ±
0.7, p = 0.000). There were fewer emergency department visits
in the intervention group compared with the control group
(0.017 ± 0.48 vs. 0.19 ± 0.48, p = 0.017); however, these patients
visited sooner in case of a complication than patients from the
control group (7.9 vs. 53.9 days, p = 0.016). No differences were
found between the groups regarding the clinical variables of
walking distance, claudication distance, and need for surgery.
The authors concluded that the use of the CONTECI program is
feasible, promotes patient expertise, and is of added value
without clinical inferiority to conventional management.
Duscha et al. [28] investigated the effect of a 12-week
home-based mobile health intervention on the functional
capacity and physical activity patterns of sedentary patients
with intermittent claudication. Before randomization and dur-
ing weeks 11 and 12, all patients wore a Fitbit Charge (Fitbit,
Inc., San Francisco, CA) device for activity tracking. The study
randomized 20 patients between intervention and standard of
care. The intervention group (n = 10) received weekly e-mails
with a PAD tip and monthly feedback with exercise prescrip-
tions based on the number of steps per day measured with
the Fitbit. Patients in the intervention group showed signifi-
cantly more improvement compared with the control group in
differences between pre- and post-intervention claudication
onset time (204.6 ± 280.6 s vs. – 21.0 ± 142.7 s, p < 0.05),
maximum oxygen consumption volume (20.3% ± 26.4% vs.
1.0% ± 6.9%, p < 0.05), and peak walking time (227.6 ± 286.5
s vs. 22.4 ± 107.7 s, p < 0.06). Daily step counts were not
significantly different between the groups. These findings
indicate that a mobile health intervention as an alternative
to supervised site-based exercise therapy for PAD patients
might be effective and additionally could provide a long-
term solution after completing such a supervised program,
especially for those not able to attend on-site supervised
exercise therapy.
McDermott et al. [27] also developed a home-based mon-
itored exercise program for PAD patients. The aim of their
trial was to investigate whether a 9-month intervention,
based on telephone coaching and wearable activity monitor-
ing, could improve walking endurance and patient-reported
outcomes. The intervention group comprised 97 randomly
assigned patients who received individualized coaching on
exercise goals and challenges. A website accessible to both
patient and coach was used to enter exercise goals by
a coach during telephone contact (subsequently once
weekly, every 2 weeks, or every month over a 9-month per-
iod), enter the walking exercise minutes by the participant;
and upload data from a Fitbit Zip (Fitbit, Inc., San Francisco,
CA) device via Bluetooth. The control group (n = 101)
Table 3. Excluded studies.
First author, year Sample size Study design Exclusion reason
Mullenheim, 2018 NA Comment Design: editorial letter
Shalan, 2018 NR App design No telemonitoring intervention
Cornelis, 2017 99 Questionnaire No telemonitoring intervention
Michard, 2017 NA Overview Design: literature overview
Gunter, 2016 9 App design No health-related outcome measures
Mercer, 2016 32 Focus groups No peripheral arterial diseases
Greving, 2015 330 RCT No health-related outcome measures
Dhukaram, 2012 34 Focus groups No peripheral arterial diseases
Boyes, 2009 2 Case reports Design: case reports
Unknown NA NA No full-text available
Wu, 2016 NA Prototype development No health-related outcome measures
Garcia, 2015 5 App design No health-related outcome measures
NA = not applicable, NR = not reported, RCT = randomized controlled trial.
6 M. E. HAVEMAN ET AL.
received standard of care and were contacted by phone
every 3 months to obtain information on physical activity
and walking exercise frequency. The increase in the number
of episodes of walking exercise per week was significantly
greater in the intervention group than in the control group at
3 months (2.0 ± 3.7 vs. 0.7 ± 2.5, p = 0.005) and 6 months of
follow-up (2.8 ± 7.3 vs. 0.9 ± 3.3, p = 0.045) but not at 9
months of follow-up (1.9 ± 5.0 vs. 0.8 ± 2.9, p = 0.09). No
significant differences were found between both groups at 9
months of follow-up in the 6-min walking distance or physi-
cal functioning score on the 34-Item Short Form Health
Survey. Remarkably, the control group reported
a significantly greater decrease in the PROMIS-measured
pain interference score for daily activities at the 9-month
follow-up compared with the intervention group (−2.8 [−4.6
to −1.0] vs. 0.7 [−1.1 to 2.6], p = 0.002). The authors con-
cluded that their home-based exercise intervention with tel-
ephone counseling and wearable activity monitoring without
periodic onsite visits did not improve walking performance in
patients with PAD, partly because the counseling was too
infrequent.
Normahani et al. [24] conducted a pilot RCT to investigate the
effect of a feedback-enabled wearable activity monitor on walk-
ing distances and QoL in patients with intermittent claudication.
The study randomized 37 patients to an intervention group (n =
20) or a control group (n = 17). During 12 months, patients in
the intervention group wore a Nike+ FuelBand (Nike, Inc.,
Beaverton, OR) around their wrist that recorded their activity
and gave real-time feedback about the progression toward daily
goals, so-called ‘fuel points’, a measure for overall movement
and activity. Daily goals were adjusted at each follow-up visit at
3, 6, and 12 months based on the percentage of days that the
fuel points targets were achieved. Maximum walking distances
(MWD), claudication distance (CD), and scores on the Vascular
Quality of Life (VascuQoL) questionnaire (scale 1–7) were col-
lected before randomization and during each follow-up visit.
Patients in the intervention groups showed significant improve-
ments between baseline and 3-, 6-, and 12-month MWD, CD,
and VascuQoL, whereas patients in the control group did not. At
3 months, however, the magnitude of change did not differ
between the intervention and control group in MWD (15.5 vs.
20 m, p = 0.78) and CD (11.5 vs. 8 m, p = 0.32), but differed
significantly in VascuQoL (0.78 vs 0.04, p = 0.004). At the 6- and
12-month follow-up, the magnitude of change compared with
baseline was significantly higher in the intervention group than
in the control group. The authors concluded that wearable
activity monitors promote physical activity and might be bene-
ficial in improving physical function and QoL in PAD patients.
4. Discussion
Rapid development of new technologies offers many advantages
of telemedicine in patients with PAD. Telemedicine has the poten-
tial to improve clinical outcome, QoL, and cost-effectiveness of
health-care interventions; however, the literature on its application
is scarce. This systematic review identified six studies focused
mainly on telemonitoring and telecoaching. The studies indicate
that telemedicine interventions can aid in the early detection of
postoperative complications, improve functional capacity, reduce
claudication onset time, and improve patients’ expertise and QoL.
These findings, however, are based on limited numbers of
patients, and the studies show conflicting results.
The aim of this review was to give an overview of the
current use of telemedicine for monitoring patients with per-
ipheral arterial disease. Since interventions for PAD patients
are either supervised exercise therapy or revascularization
(surgery), telemedicine applications for these patients include
either monitoring of claudication exercise programs to
increase walking distance or postoperative wound care and
wound-related complications. The main differences between
studies using one of these types of telemonitoring are the
type of devices used (i.e. activity monitoring vs. application to
upload wound pictures) and outcome parameters (i.e. walking
performance measures vs. wound complication).
Treadmill exercises are recommended as the first line of
therapy for patients with intermittent claudication because
they have been shown to improve functional outcome [18].
Supervised exercise programs are preferred because unsuper-
vised programs lack compliance [19]. Participation is still lim-
ited, however, because a supervised program requires
multiple visits to an exercise center. The study of Gardner
et al. showed that a step-monitored home exercise program
could improve the 6-min walk distance even more than super-
vised exercises in these patients [20]. Calf muscle oxygen
saturation, vascular function, and inflammation were also
shown to improve [20].
These results were, however, not confirmed by McDermott
et al. [27], who suggested that this might be due to [1] remote
coaching being less potent than in-person visits [2];
a mismatch between wearable activity monitoring and exer-
cise recommendations, because the first led to an increase in
overall activity level rather than to an increase in walking
exercise; and [3] too infrequent counseling. This covers impor-
tant factors that might withhold the implementation of tele-
medicine interventions in this patient population.
Traditionally, most vascular patients are regularly moni-
tored 6 weeks post-intervention at the out-patient clinic. This
holds the risk that SSIs will be missed or diagnosed late
because most infections will occur <6 weeks after the inter-
vention. Telemedicine interventions can fill this unmet need
because physicians can monitor their patients at any time.
Moreover, telemedicine can reduce unnecessary visits, over-
come the problem of transportation issues, and enhance self-
awareness, -diagnosis, and -management in vascular patients
[17,25,26,28]. What the optimal frequency is for monitoring of
these patients is still questionable, however. Only one study
described the monitoring of vital parameters in patients after
vascular surgery. Mousa et al. [17] described the number of
alerts based on these data (a total of 134); however, they did
not mention the association between the alerts and caregiver
contact or actual complications.
The most important methodological study limitations of the
included papers are a limited number of studied patients or
biases in patient inclusion and assignment to groups. Davins
Riu et al. [25] concluded that their study was biased by selection
of patients in which a telehealth program was most likely to
benefit (patients with intermittent claudication symptoms,
Fontaine stage II). Duscha et al. [28] studied a small sample size
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(10 patients in the intervention arm versus 9 patients in the
standard of care arm) without preconceived power calculations.
The control group might have introduced biases, because of the
tendency to be older and weigh more, and because the treat-
ment assignment was not blinded. Gunter et al. [26] performed
their study on a small sample size of 40 patients from a relatively
homogenous population who were familiar with the technology.
McDermott et al. [27] stated that their results might not be
extrapolated to patients not interested in increasing exercise
activity level, that the exercise intervention was not potent
enough due to the absence of direct feedback on uploaded
data, and that they missed substantial data for objective mea-
surement of physical activity. The study of Mousa et al. [17] was
underpowered, since only 30 of the 80 screened patients were
enrolled. In the study of Normahani et al. [24], approximately half
of the eligible patients declined to participate which resulted in
a study population of only 37 patients. Besides, both the inter-
vention and control group had access to a supervised exercise
program (SEP), which makes it difficult to separate the effects of
wearable activity monitoring from that of the SEP. However, only
15% (3 patients) of the patients from the intervention group and
29% (5 patients) from the control were enrolled in SEP.
Implementation of telemedicine interventions in patients
PAD requires careful consideration. First, the balance between
unsupervised periods and frequency of contact is delicate. The
optimal frequency of real-life contact between patient and
caregiver/coach has not yet been determined and probably
cannot be completely replaced by teleconsultation.
Second, technology apprehension could play an important
role in the adherence of patients to the telemedicine inter-
vention. PAD patients are relatively old, and Cornelis et al.
reported that only 26% of the PAD patients who owned
a mobile phone (92 of 99) used apps [21]. Gunter et al. [26]
had to exclude 32.5% of the patients in their study if they
would not have provided smartphone devices for patients
who did not own a suitable one. In the RCT of Mousa et al.
[17], 9 of 80 patients screened for inclusion refused because of
apprehension toward technology. Provision of a smartphone
increases the applicability to the complete patient population;
however, relying on patients’ own devices provides the advan-
tage of patients’ familiarity with technology and reduces the
need for extra training [25]. Another bias due to technology
apprehension in telemedicine studies is that patients who are
successfully recruited are more inclined to use technology,
lowering the generalizability of these studies [24].
Third, compliance might also bias control groups. A pitfall
of non-randomized studies is that less committed patients
might prefer home-based exercise to medical center visits.
Patients in the control groups might have decided to increase
exercise themselves. Attention-control intervention designs
might be able to overcome this bias [27].
This systematic review has limitations. The heterogeneity of
the reported studies in types of intervention, outcome mea-
sures, and follow-up duration conceptually eliminated quanti-
fication of outcome heterogeneity and precluded pooling of
data to perform a meta-analysis. This precludes a definitive
answer to the question whether telemedicine interventions
are worth the effort.
Another limitation is that only health outcome measures
were included, whereas current literature regarding telemedi-
cine in vascular patients also emphasizes the importance of
feasibility (acceptability, satisfaction, etc.) for patients and
caregivers. Although not incorporated in the current review,
feasibility is an important factor in the implementation of
telemonitoring interventions. For example, a strength of the
study of McDermott et al. [27] is that they designed their
exercise intervention based on patient feedback during earlier
held focus groups and pilot studies in PAD patients.
Noteworthy is that multiple studies report high levels of satis-
faction and feelings of reassurance owing to the telemedicine
intervention [17,26].
Cost-effectiveness is another relevant factor that requires
more attention be given to the question of whether telemonitor-
ing is worth the effort. In (most) studies, cost-effectiveness is
mentioned as a possible advantage of telemonitoring [17,24–
26]; however, data regarding cost-effectiveness are rarely pro-
vided, and mainly based on assumptions. Assessment of cost-
effectiveness in healthcare should include both costs and effects
within the healthcare system (such as costs of hospital stay) as
well as costs outside this system (such as sick leave and travel
costs) [22]. In a cost-effectiveness evaluation of a nurse-led inter-
net-based vascular risk management program, Greving et al. [23]
took into account medical costs, including medication and staff
labor costs, and non-medical costs, including transportation
costs and costs from paid and unpaid productivity losses.
Depending on the type of telemedicine, costs of devices need
to be added to such a list.
Three papers were excluded because outcome measures
were the usability of a smartphone application. Shalan et al.
[9] designed the YORwalK app to promote exercise in PAD
patients. So far, they have tested the usability only in health-
care professionals. Garcia et al. [10] described the use of an
Android application based on geolocation to control home-
based exercise in five PAD patients. Gunter et al. [11] assessed
the usability of the WoundCheck app, which they used for
a feasibility study that was included in the current review [26].
One excluded paper described how wound progress in leg
ulcer care could be followed through photographs based on
two case reports [12]. Most excluded papers did not cover
telemedicine interventions or did not include patients with
PAD, but, for example, patient with chronic cardiovascular
diseases [13,14]. This emphasizes the limited availability of
reports about the use of telemedicine in PAD patients.
5. Expert opinion
Telemedicine can potentially benefit patients with PAD. There
are, however, some practical issues that need to be overcome
before this can successfully be implemented in daily clinical
practice. Patients feel satisfied and in control at the beginning
of a telemedicine intervention, but at a certain point, the
intervention becomes routine and motivation decreases [25].
Game-based interventions could possibly have a positive influ-
ence on exercise attitudes in vascular patients [15]. Patient
input in the development of personalized telemedicine from
focus groups and pilot studies might also benefit patient
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engagement towards such programs. Furthermore, Gunter
et al. [26] mentioned concerns about program sustainability
because of extra workload for nurses due to the in-hospital
explanation of the intervention and processing of app infor-
mation during their normal work activities. Sustainability
depends on integration within the health-care system [26]
and incorporation into a daily routine [24]. The latter is highly
dependent on the type of devices used. For example, the ease
of use of telemedicine tools (tablets, smartphone, applications,
measurement instruments), the presence of feedback [24], and
level of control will probably influence patients’ adherence
toward telemedicine programs.
The increasing technological potential of wearable devices
as a result of the development of smaller sensors and accom-
panied algorithms enables the measurement of more (impor-
tant) clinical parameters and, therefore, the monitoring of
patients anywhere. One well-known wearable sensor is the
Fitbit, which was used for activity measurements in two of
our included studies [27,28]. The Fitbit is shown to be useful in
other fields of medicine as well. Higher Fitbit step counts
during inpatient recovery can predict lower readmission
rates after metastatic peritoneal cancer surgery [16]. The Nike
+ FuelBand was used in one study [24] and has shown to be
effective because of its ability to visualize the progress toward
daily activity goals. Currently, wearable sensors are developed
to monitor a range of vital parameters of patients remotely for
earlier detection of post-operative deterioration [29–32].
Recently, Joshi et al. [29] presented an overview of these
sensors. So far, main challenges of technology for telemonitor-
ing are [1]: improvement of the diagnostic accuracy of these
sensors and algorithms as well as the improvement of battery
use and capacity [2]; the measurement of (continuous) wire-
less, non-invasive blood pressure [3]; adequate alarm criteria;
and [4] privacy and storage of data. Electronic applications
enable remote consultation between patients and health-care
professionals [33] and can be used to: monitor patients well-
being through wound monitoring or experience sampling
(measuring experiences of daily life, such as pain and fear);
inform patients about their treatment; and provide feedback
and coaching.
Furthermore, telemonitoring could already be of additional
value in the pre-operative phase by providing information for
pre-operative screening, decision-making, and optimizing
patients before surgery. The latter is known as prehabilitation,
which is currently of increasing interest and is based on the
‘better in, better out’ principle [34]. In PAD patients, telemedi-
cine could assist in prehabilitation by activity monitoring and
coaching, for example, in patients who receive supervised
exercise therapy from a physical therapist. Furthermore,
mobile applications that consist of information and question-
naires can play an important role in (pre-operative) secondary
risk prevention by lifestyle management coaching in this fra-
gile population.
During the complete care trajectory of PAD patients (hos-
pitalized or not), implementation of continuous monitoring
with wearable devices could not only be used for earlier
detection of deterioration but might also reduce the workload
for nurses and contribute to patients’ comfort and satisfaction.
However, what the optimal frequency is for monitoring and in
which phase of care is unclear: continuously, hourly, daily,
weekly? A pilot study in which patients are monitored in the
complete peri-operative trajectory to answer these questions
would be beneficial. Subsequently, the effects of implementa-
tion of telemedicine interventions in PAD patients should be
further explored in larger randomized controlled trials.
It is remarkable that such an important outcome as cost-
effectiveness of telemonitoring (in PAD or other patient
groups) is still an underexplored area. The following factors
are to be considered in future cost-effectiveness assessments.
First, the economic evaluation of telemonitoring interven-
tions requires proper implementation in healthcare. Second,
the definition of a cost or effect in the evaluation of tele-
medicine interventions compared to usual care relies on the
policy level of interest [22], whether it comprises cost-
effectiveness at the level of government, hospital or patient.
Third, although economic evaluation of telemedicine inter-
ventions will influence its availability in the future healthcare,
the success of such implementations probably also depends
on hardly measurable subjective perceptions of both care-
givers and patients, such as workload and feeling of security,
respectively.
Standardization in reporting on outcomes of the use of
telemedicine is important and further development of teleme-
dicine guidelines is necessary. One of the important initiatives
is from the American Telemedicine Association which made
progress to prioritize such guidelines and development of
telemedicine standards [35]. Physicians all over the world
implementing telemedicine and studying the effects of tele-
medicine in healthcare should be encouraged to work accord-
ing to these standards. Moreover, finetuning of global
telemedicine guidelines and standardization in reporting on
outcomes should be on the agenda in the world-leading tele-
medicine conferences.
In conclusion, the use of telemedicine in PAD patients is still
an under-explored area. Owing to its high potential to improve
physical ability, lifestyle coaching, and detection of deterioration
in these patients, future research should focus on the proper
implementation of telemedicine in PAD patients, including clin-
ical, feasibility, nurses’ workload, and cost-efficiency outcome
measures. Over the next years, accompanied by technological
improvements, telemedicine will be integrated into many fields
of health care, reinforcing the tendency toward personalized
medicine, facilitating the migration of care toward home, and
inhibiting rising health-care costs.
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